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Lysosomal exocytosis is a Ca2+-regulated mecha-
nism that involves proteins responsible for cytoskel-
etal attachment and fusion of lysosomes with the
plasma membrane. However, whether luminal lyso-
somal enzymes contribute to this process remains
unknown. Here we show that neuraminidase NEU1
negatively regulates lysosomal exocytosis in hema-
topoietic cells by processing the sialic acids on the
lysosomal membrane protein LAMP-1. In macro-
phages from NEU1-deficient mice, a model of the
disease sialidosis, and in patients’ fibroblasts, over-
sialylated LAMP-1 enhances lysosomal exocytosis.
Silencing of LAMP-1 reverts this phenotype by inter-
fering with the docking of lysosomes at the plasma
membrane. In neu1–/– mice the excessive exocytosis
of serine proteases in the bone niche leads to inacti-
vation of extracellular serpins, premature degrada-
tion of VCAM-1, and loss of bone marrow retention.
Our findings uncover an unexpected mechanism
influencing lysosomal exocytosis and argue that
exacerbations of this process form the basis for
certain genetic diseases.
INTRODUCTION
Conventionally lysosomes have been viewed as the final stage in
the degradation or recycling of endocytic or autophagocytic
macromolecules by specialized hydrolases (Kornfeld and Mell-
man, 1989). Their importance in normal cell homeostasis is
emphasized by the many genetic defects that hamper lysosomal
degradation and cause disease (Sandhoff et al., 2001). In addi-
tion to their general digestive capacity, lysosomes serve a multi-
tude of basic cellular functions, including downregulation of
membrane receptors, disruption of internalized pathogens, and
processing of MHC class II antigens (Li et al., 2005; Ni et al.,
2006; Seto et al., 2002). Lysosomes are also actively involved
in specialized, regulated functions that reflect the physiological
properties of individual cell types. For example, secretory lyso-
somes, which are present in melanocytes and hematopoietic
cells, contain in addition to their usual composite of lysosomal
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through an acidic compartment prior to secretion. These spe-
cialized lysosomes expel their content by lysosomal exocytosis,
a regulated process that entails recruitment/docking of lyso-
somes to the plasma membrane (PM), followed by the Ca2+-
dependent fusion of the lysosomal membrane (LM) with the PM,
so that the luminal side of the LM becomes exposed extracellu-
larly (Andrews, 2000; Bossi et al., 2005; Bossi and Griffiths, 2005).
Exocytosis of lysosomes has now emerged as a fundamental
mechanism in physiologic and pathologic processes such as re-
plenishment of the PM in macrophages, repair of damaged PM,
and the removal of pathogenic bacteria or the release of human
immunodeficiency virus from infected cells (Huynh et al., 2004;
Jaiswal et al., 2002; McNeil and Steinhardt, 2003; Reddy et al.,
2001; Roy et al., 2004). Numerous gene defects are known to
be associated with impaired exocytosis of secretory lysosomes
in cytotoxic T lymphocytes, platelets, and melanocytes; these
diseases share the common clinical features of immunodefi-
ciency, bleeding disorders, and albinism (Stinchcombe et al.,
2004). Characterization of these genetic lesions has identified
proteins required for the movement of lysosomes along the mi-
crotubule network, fusion with the PM, and ultimately exocytosis
of their luminal content (Bossi et al., 2005; Bossi and Griffiths,
2005). However, whether lysosomal luminal proteins participate
in this process is not yet known.
Recent studies suggest that components of the LM itself play
a pivotal role in exocytosis. The ubiquitously expressed lyso-
somal synaptotagmin VII (Syt VII) is a Ca2+ sensor that is
anchored to the LM by a single transmembrane domain, while
most of the protein is exposed to the cytosol. Syt VII cooperates
with V- and T-soluble N-ethylmaleimide sensitive factor attach-
ment receptor (SNARE) proteins in promoting the fusion of the
LM with the PM (Andrews and Chakrabarti, 2005; Gerasimenko
et al., 2001; Kima et al., 2000; Martinez et al., 2000). Deficiency
of Syt VII in mice hampers lysosomal exocytosis, leading to de-
creased LM-mediated PM repair and the onset of autoimmune
myositis (Chakrabarti et al., 2003).
LAMP-1 is an important structural constituent of lysosomes
localized abundantly in the limiting membrane of the organelle
and sparsely at the PM, unless cells undergo exocytosis (Furuno
et al., 1989; Lippincott-Schwartz and Fambrough, 1987). In con-
trast to Syt VII, its primary structure consists of a highly glycosy-
lated and sialylated N-terminal portion oriented toward the
lumen, a short cytoplasmic tail, and a single transmembrane
Developmental Cell
NEU1-Regulated Exocytosis of Lysosomesdomain (Eskelinen et al., 2003). LAMP-1 has been implicated in
the process of lysosomal exocytosis, because its overexpres-
sion was shown to increase its abundance at the PM and to en-
hance lysosomal exocytosis of b-hexosaminidase (Kima et al.,
2000). However, the physiological relevance of this effect is un-
clear, as LAMP-1mutant mice appear to have a very mild pheno-
type (Andrejewski et al., 1999).
Over half of the hydrolases deficient in lysosomal storage
diseases (LSDs) are carbohydrate-cleaving exoglycosidases.
Among them, N-acetyl-a-neuraminidase (NEU1, sialidase) initi-
ates the catabolism of sialo-glycoconjugates by removing their
terminal sialic acid residues (Bonten et al., 1996; Rottier et al.,
1998). Neu1 gene mutations in humans cause sialidosis, a clini-
cally heterogeneous autosomal recessive LSD that targets pri-
marily the reticuloendothelial system. Sialidosis patients have
a severe systemic disease, which includes hepatosplenomegaly
and involvement of the nervous system (Thomas, 2001). Neu1
knockout (KO) mice closely mimic the human condition, and
develop a pronounced, age-dependent splenomegaly charac-
terized by elevated numbers of hematopoietic progenitors,
consistent with splenic extramedullary hematopoiesis (EMH)
(de Geest et al., 2002).
Although much is known about the lysosomal enzymes that
are deficient in LSDs, there is a lesser understanding of the range
of natural substrates they target in vivo and how accumulation or
lack of processing of such substrates may contribute to the path-
ogenesis of each disorder. Here, we have identified LAMP-1 as
a target substrate of NEU1. We found that in neu1–/– hematopoi-
etic cells an oversialylated form of LAMP-1 accumulates at the
PM, and is associated with enhanced lysosomal exocytosis of
catalytically active hydrolases. The resulting increase in extracel-
lular proteolytic activity leads to premature degradation of vas-
cular cell adhesion molecule-1 (VCAM-1), which is crucial for
bone marrow (BM) retention in the bone niche. Our results iden-
tify NEU1 as a negative regulator of lysosomal exocytosis, and
link an exacerbation of this process to a disease condition.
RESULTS
Extracellular Clade-A Serpins Are Downregulated
in the neu1–/– Bone Niche
To explain the EMH phenotype characteristic of neu1–/– mice
(de Geest et al., 2002) we argued that a loss of NEU1 activity
could lead to changes in the BM microenvironment, and, in
turn, to loss of BM retention and/or homing. This became evident
after a series of bone marrow transplantations (BMTs), in which
NEU1-expressing transgenic BM was transplanted into suble-
thally irradiated neu1–/– mice. Treated mice showed consistently
successful short-term engraftment (10 days post-BMT), but
failed long-term engraftment (n = 25; > 16 days post-BMT),
whereas all control BMTs into wild-type (WT) mice showed sus-
tained short- and long-term engraftment (n = 8; data not shown).
These results demonstrated a defect in BM retention rather than
in BM homing.
We reasoned that EMH and lack of BM engraftment in neu1–/–
mice could have a common determinant, namely impaired pro-
cessing of sialic acid on glycans of yet unknown NEU1 targets
that would affect their biochemical properties. In fact, using a
sialic acid detection assay, we showed that neu1–/– total BMextracts contained high levels of sialylated proteins compared
to WT (see Figure S1 available online). We next performed com-
parative proteomic analyses of the BM extracellular fluid (BMEF)
from neu1–/– and neu1+/+ mice to identify proteins that were
deregulated by the loss of NEU1. Total protein preparations
from the two BMEFs were analyzed on 2-dimensional (2D) SDS
gels and selected single-protein spots identified by MALDI-TOF
(Figure 1A). The most overt difference was a reduction in the
neu1–/– BMEF of two clusters of uncleaved, clade A serine prote-
ase inhibitors, serpina1 and serpina3 (Figure 1A). Serpins are
present extracellularly in two forms: an uncleaved inert form
and a cleaved activated form. Specific serine proteases cleave
the reactive center loop of serpins, which allows them to cova-
lently bind and inactivate these proteases; the resulting serpin-
protease complexes (SECs) are rapidly cleared from the body
(Winkler et al., 2005). Discrete spots on the 2D gels represented
both the uncleaved (closed ovals) and cleaved (dashed ovals)
serpins, as well as different variants derived from multiple
serpina1and serpina3genes (Borriello and Krauter, 1991; Forsyth
et al., 2003). Both inhibitors were readily detected by immunohis-
tochemistry (IHC) in the extracellular matrix (ECM) of WT bone
sections, where they normally bind to specific glycosaminogly-
cans (Patston et al., 2004); however, they were drastically re-
duced in KO bone sections (Figure 1B). Western blot analysis of
neu1+/+ and neu1–/– BMEFs confirmed these results
(Figure 1C). The decreased levels of uncleaved serpins in
neu1–/– BMEF were likely due to excessive processing of these
proteins, because their mRNA levels were unchanged (data not
shown).
The physiological excess of clade A serpins in plasma and
BMEF (Winkler et al., 2005) reflects their role in controlling the
load of potentially harmful free serine proteases. We therefore
asked whether the decreased levels of uncleaved serpins in
neu1–/– BMEF was due to an abnormal increase of serine prote-
ases. To test this hypothesis, we incubated recombinant human
SERPINA1 (rSERPINA1) with neu1–/– BMEF, which indeed re-
sulted in the in vitro formation of SECs of higher molecular weight
(MW) than the unbound species; SECs were not formed with WT
BMEF (Figure 1D).
Increased Levels of Neutrophil Serine
Proteases in neu1–/– BMEF
A crucial process for the maintenance of BM homeostasis is the
regulated exocytosis of serine proteases, such as neutrophil
elastase (NE) and cathepsin G (CG), by neutrophils that degranu-
late their secondary granules (secretory lysosomes) into the
BM-ECM (Levesque et al., 2001). We therefore tested the
expression pattern of these proteases by IHC of bone sections.
A drastically reduced intracellular staining of NE and CG was ob-
served in neu1–/– sections compared to WT (Figure 1E). Con-
versely, elevated amounts of these proteases were detected in
the neu1–/– BMEF (Figure 1F), indicating abnormal extracellular
release of these proteases.
To validate this observation, we performed casein zymogra-
phy that detected additional serine proteases in neu1–/– BMEF
not present in the WT sample (Figure 1G). One of these was un-
equivocally identified as CG by using a selective CG inhibitor that
completely abolished a low MW band present only in neu1–/–
BMEF (Figure 1G, yellow diamond). We could not determine
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BMEF, albeit their activities were inhibited upon incubation
with a selective elastase inhibitor, suggesting that they might
have overlapping elastase activity (Figure 1G, blue diamond).
High Elastase Activity in neu1–/– BMEF Degrades
VCAM-1 and Causes Loss of Retention of BM
Progenitors in the Bone Niche
Based on the above results, we next determined the relative
amount of endogenous VCAM-1 in neu1–/– BM stromal cells
(BMSCs). BM progenitor cells are retained in the bone niche
by chemotactic interactions between CXCL-12 and CXCR-4,
and adhesive interactions between the b-integrin VLA-4 and
VCAM-1. We found no differences in the levels of CXCR-4 and
VLA-4 protein between KO and WT samples (data not shown).
We, therefore, focused on VCAM-1 because it is expressed on
the surface of BMSCs, is crucial for the homing and retention
of BM cells in the bone niche, and is proteolytically regulated
by serine proteases (Levesque et al., 2001). VCAM-1 protein
levels were abnormally low in neu1–/– BMSC extracts compared
to WT (Figure 2A). This was occurring posttranslationally,
Figure 1. Serpins Are Downregulated in the
Neu1–/– Bone Niche by Increased Exocytosis of
Neutrophil Serine Proteases
(A) Two-dimensional electrophoresis of BMEFs from KO
and WT littermates; uncleaved serpina3 (blue circles)
and serpina1 (red circles); cleaved serpina1 and serpina3
(dashed circles).
(B) Bone tissue sections probed with anti–serpina1 and
anti–serpina3.
(C) Immunoblots of WT and KO BMEF probed with ser-
pina1 and serpina3 antibodies. Coomassie brilliant blue
(CBB) staining showed equal loading.
(D) Immunoblots of recombinant SERPINA1 after incuba-
tion with KO and WT BMEF.
(E) Immunostaining of WT and KO bone sections with anti-
CG and anti-NE antibodies.
(F) Immunoblots of WT and KO BMEF with anti-CG and
anti-NE antibodies.
(G) Casein zymography of WT and KO BMEF in the pres-
ence and absence of CG and elastase inhibitors. Serine
protease inhibited by the CG inhibitor (yellow diamond,
middle panel); high MW serine protease inhibited by the
elastase inhibitor (blue diamond, right panel).
because vcam-1 mRNA levels were identical in
KO and WT BMSCs (data not shown). More-
over, in total BM isolated from neu1–/– mice of
different ages, the amount of VCAM-1 de-
creased progressively as the animals aged
(Figure 2A). These data were validated by
FACS analyses of BM that detected a lower
number of VCAM-1+ cells in the neu1–/– sample
compared to WT (Figure 2B), and by IHC of
bone sections that showed reduced VCAM-1
levels in the neu1–/– stromal cells lining the
bone cavity (Figure 2C, arrows).
To support the hypothesis that the decrease
in VCAM-1 in KO cells was caused by enhanced
proteolytic activity extracellularly, we incubated
recombinant human VCAM-1 (rVCAM-1) with neu1–/– or neu1+/+
BMEFs and only observed the generation of numerous low-MW
digested VCAM-1 products with neu1–/– BMEF (Figure 2D, left
panel). Proteolysis of rVCAM-1 was prevented by an elastase in-
hibitor (Figure 3D, right panel), confirming the presence of high
elastase activity in the KO BMEF. Furthermore, incubation of
cultured BMSCs with neu1–/– BMEF, but not with WT BMEF, re-
sulted in the cleavage of VCAM-1. This cleavage was blocked by
the serine protease inhibitor PMSF (Figure 2E). From these data
we inferred that the abnormally high serine protease activity
toward VCAM-1 in the neu1–/– BMEF could hamper the capacity
of the BMSCs to retain hematopoietic progenitor cells (HPCs) in
the bone niche.
We verified this hypothesis by performing cell adhesion assays
between cultured WT BMSCs and purified c-Kit+/Sca1+/Lin–
HPCs (Levesque et al., 2001). To mimic the BM microenviron-
ment of NEU1-deficient mice we incubated WT BMSCs with
increasing concentrations of neu1–/– BMEF. This gradually pre-
vented the adherence of HPCs to the BMSC layer (Figure 2F).
In contrast, neu1+/+ BMEF had no such effect. In agreement
with these results, we observed an increased mobilization of
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mice, which was accompanied by a reduction in the number of
these cells in the neu1–/– BM (Figure 2G). Together these findings
may explain the time-dependent loss of BM retention in the bone
niche of KO mice and provide a rationale for the occurrence of
EMH in this mouse model.
Neu1–/– Mice Have Enhanced Lysosomal
Exocytosis in the Bone Niche
We reasoned that the excess of proteolytically active serine pro-
teases in the BMEF of KO mice (Figure 1) could only be the result
of increased lysosomal exocytosis of BM cells, because these
enzymes are normally synthesized as zymogens and converted
to their mature, active forms in the endo/lysosomal compartment
(Kominami et al., 1988). We therefore analyzed by FACS the per-
centage of neu1–/– and neu1+/+ BM cells with LAMP-1 at their
PM, a parameter used to distinguish cells engaged in lysosomal
exocytosis. A clear increase in the percentage of LAMP-1+ cells
was detected in the neu1–/– total BM compared to WT
(Figure 3A). The difference in number of LAMP-1+ cells between
Figure 2. Elevated Elastase-like Activity in
Neu1–/– BMEF Proteolytically Degrades
VCAM-1
(A) Immunoblots of BMSC and BM lysates from WT
and KO mouse littermate pairs of different ages (1, 3,
and 5 months, respectively) probed with anti-VCAM-1
antibody.
(B) FACS profiles of KO BM obtained with FITC-conju-
gated VCAM-1 antibody. Dotted graphs represent IgG
isotype controls set at 0%.
(C) Bone sections from 2-month-old KO and WT mice
stained with anti-VCAM-1; strong immunoreactivity
only in WT sections in the region lining the bone
(arrows).
(D) Aliquots of rhVCAM-1 were incubated with BMEF
from WT and KO mice in the presence or absence
(PBS) of an elastase inhibitor and analyzed on immuno-
blots probed with anti-VCAM-1 antibody.
(E) Incubation of WT BMSCs with WT and KO BMEF in
presence or absence of serine protease inhibitor
PMSF, followed by immunoblot analysis using anti-
VCAM-1 antibody.
(F) WT BMSCs were incubated with increasing con-
centrations of WT or KO BMEF, followed by addition
to the culture of fluorescently labeled WT BM-derived
HPCs. Retained HPCs were quantified by measuring
the fluorescence. Values are presented as mean ±
SEM.
(G) FACS analysis of c-Kit+/Sca1+/Lin– HPCs; age of
mice, 4 months; n = 4; values represent the mean ±
SEM.
WT and KO was even greater in sorted
neutrophils (60-fold increase in the KO
sample)(Figure 3B). These cells are the
main source of extracellular serine protease
activities (NE and CG) in the bone niche,
which they release via lysosomal exocytosis
of LAMP-1+ secretory granules (Dahlgren
et al., 1995). Hence, the increased number
in the neu1–/– BM of neutrophils with LAMP-1 at their PM likely
accounted for the increased levels of these enzymes in the
BMEF.
Because cell-surface expression of LAMP-1 by itself was not
a quantitative indicator of lysosomal exocytosis, as a functional
read-out of this process we measured the enzyme activities of
several other lysosomal cathepsins and glycosidases in BMEF
samples. These enzymes are stored in LAMP-1+ conventional ly-
sosomes of most BM cells, and are normally not present at high
levels extracellularly. However, these enzyme activities were
found to be 4- to 6-fold higher in neu1–/– BMEF than in the WT
BMEF (Figure 3C). By contrast, the same enzyme activities mea-
sured in the BMEF from b-galactosidase-deficient (b-gal-KO)
mice, a model of the LSD GM1-gangliosidosis (Hahn et al.,
1997), were normal, indicating that the exocytic release of active
lysosomal hydrolases was intrinsic to the NEU1 deficiency and
not a feature shared by other LSDs (Figure 3C).
LAMP-1 Is a Natural Substrate of NEU1
To reconcile the loss of NEU1 activity with the excessive lyso-
somal exocytosis of hematopoietic cells, we postulated a role
Developmental Cell 15, 74–86, July 2008 ª2008 Elsevier Inc. 77
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have been implicated in the exocytic process, thereby changing
their properties. Using primary macrophage cultures (Bonten
et al., 2004) as an in vitro model of exocytic cells, we first deter-
mined that NEU1 was not involved in the processing of two
LM-anchored proteins, Syt VII and VAMP7, which participate in
the LM-PM fusion (Andrews and Chakrabarti, 2005; Kima
et al., 2000). On immunoblots these proteins showed an identical
mobility pattern and expression level in KO and WT macro-
phages (Figure S2). Also the T-SNAREs, syntaxin4 and
SNAP23, which are anchored to the PM (Stinchcombe et al.,
2004) were unaltered (Figure S2). Thus, NEU1 deficiency does
not affect proteins that are part of the fusion machinery.
In contrast, immunoblots of total macrophage lysates probed
with LAMP-1 antibodies against either the C-terminal cytosolic
domain (L1418) or the glycosylated luminal domain (1D4B), iden-
tified a LAMP-1 protein in neu1–/– cells that was increased
in amount and MW with respect to WT LAMP-1 (Figure 4A).
In vitro enzymatic removal of all N- and O-glycans released a
Figure 3. Lysosomal Exocytosis Is Increased in the Neu1–/– Bone
Niche
(A) FACS analysis of total BM cells from 3-month-old WT and KO littermates
with FITC-conjugated anti-LAMP-1 (1D4B).
(B) FACS analysis of gated Mac1+/Gr1+ BM neutrophils. Dotted graphs repre-
sent IgG isotype controls set at zero percent.
(C) Lysosomal glycosidase and cathepsin activities were measured in BMEFs
from WT, neu1–/– and b-gal–/– mice. Activities are expressed as ratios of KO
and WT values. Values represent the mean ± SD (n = 5 mice).
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phage lysates, indicating that the differential mobility of LAMP-
1 in absence of NEU1 was solely due to its glycan composition
(Figure S3A). We further demonstrated that the abnormal MW
of LAMP-1 (140 kDa) was normalized to125 kDa after recon-
stitution of NEU1 activity in deficient cells that had taken up a re-
combinant enzyme (rBV-Neu1; Figure 4B). Thus, the higher
LAMP-1 MW in KO cells was caused by oversialylation of the
Figure 4. LAMP-1 Is a Substrate of NEU1
(A) WT and KO macrophage lysates were analyzed on immunoblots probed
with anti-Lamp1 antibodies; L1418 recognizes the C-terminal peptide; 1D4B
recognizes the luminal domain.
(B) Immunoblot analysis of WT and KO macrophages with anti-Lamp1 anti-
body after uptake of rBV-Neu1 (+N).
(C and D) Pulse-chase analyses of radiolabeled LAMP-1 and Lamp-2 in KO
and WT macrophages.
(E) Immunoblot of KO macrophages probed with LAMP-1 and NEU-1 anti-
bodies; macrophages were incubated with rBV-Neu and chased for different
time periods in NEU1-free medium. Actin was used as a loading control.
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sizes and amounts of two other LM glycoproteins, Lamp-2 and
LIMP-1 (Figure S3C).
The increased LAMP-1 level in deficient cells was not due to
enhanced transcription (Figure S3B). Therefore, we performed
a pulse-chase experiment to assess the processing and turnover
of LAMP-1 in KO and WT macrophages (Figure 4C). Immunopre-
cipitation of radiolabelled proteins with L1418 antibody demon-
strated that in WT cells a 140 kDa newly synthesized LAMP-1
was converted into a 125 kDa species over a < 48 hr chase pe-
riod, and had a half-life of20 hr (Figure 4C). Instead, in KO mac-
rophages only a partially processed LAMP-1 had a half-life of >
96 hr (Figure 4C). Remarkably, the processing and turnover of
Lamp-2 was unaltered in these cells (Figure 4D). These results in-
dicate that LAMP-1 is a substrate of Neu1 and that the loss of this
enzyme preferentially decreases the turnover rate of LAMP-1.
To further investigate the effect of Neu1 on the sialylation and
stability of LAMP-1, we cultured neu1–/– macrophages in the
presence of rBV-NEU1 and then chased the internalized enzyme
in Neu1-free medium. Exposure to rBV-NEU1 reduced the MW
of LAMP-1, and its amount was less than 10% of that in un-
treated KO macrophages (Figure 4E, t = 0). During the first 4 hr
of the chase the levels of LAMP-1 remained low, in agreement
with the high amount of NEU1. In contrast, during prolonged
chase periods, the amount of NEU1 decreased drastically, which
reversed the amount and size of LAMP-1 to those detected in un-
treated KO macrophages (Figure 4E, t = 24–28 hr). Thus, NEU1 is
responsible for the processing of the sialic acid residues of
LAMP-1, which in turn increases its turnover.
Localization of Sialylated LAMP-1 at the PM of Neu1–/–
Cells Correlates with Increased Lysosomal Exocytosis
To ascertain whether oversialylation affected the abundance
and subcellular distribution of LAMP-1, neu1–/– cells were
probed with either the 1D4B (luminal domain) or L1418 (cytosolic
tail) LAMP-1 antibody and examined by immunofluorescence
and laser scanning confocal microscopy (LSCM). Under condi-
tions that permeabilized the PM, the intracellular pool of
LAMP-1+ lysosomes in KO macrophages appeared clustered
and often juxtaposed to the cell surface (Figure 5A, and
Movie S1), while in WT cells a typical punctated LAMP-1 distri-
bution was seen throughout the cytosol (Figure 5A and Movie
S2). In contrast, under conditions that did not permeabilize the
PM, LAMP-1 was present abundantly at the cell surface of KO
cells but hardly visible at the surface of WT macrophages
(Figure 5A, and Movies S3 and S4). The differential localization
of LAMP-1 in neu1–/– cells was specifically due to loss of Neu1
activity rather than mere expansion of the lysosomal com-
partment, because b-gal–/– macrophages showed a normal
LAMP-1 distribution (Figure S4).
We postulated that the preferential redistribution of LAMP-1
at the PM of KO macrophages could be a direct consequence
of increased lysosomal exocytosis in these cells. Given that
lysosomal exocytosis depends on the rapid influx of Ca2+ at
the PM, we asked whether the localization of LAMP-1 at the
PM of NEU1 deficient cells was Ca2+-dependent and whether
this was accompanied by excessive lysosomal exocytosis. Sim-
ilarly to what was observed in neutrophils, FACS analysis with
the 1D4B antibody showed a higher percentage of KO macro-phages with LAMP-1 at their cell surface compared to WT cells
(Figure 5B). Restoring NEU1 activity in deficient cells by uptake
of rBV-NEU1 reversed the cell surface localization of LAMP-1
(Figure 5B). Most importantly, WT and KO macrophages that
were maintained in Ca2+-free medium (+EGTA) for more than
2 hr prior to FACS analysis were nearly devoid of LAMP-1 at
the PM (Figure 5B). Thus, the localization of LAMP-1 at cell sur-
face of macrophages depends on the influx of Ca2+.
We further tested whether induction of lysosomal exocytosis
would differentially affect the PM localization of LAMP-1 in KO
versus WT macrophages. For this purpose cells were treated
with calcimycin, a Ca2+ ionophore that promotes the rapid influx
of Ca2+ at the cell surface and, in turn, the fusion of already
docked lysosomes with the PM (Jaiswal et al., 2002). After in-
duction, cells were cultured in Ca2+-free medium for up to 1 hr
to prevent further fusion of lysosomes with the PM (Figure 5C).
We found that purified preparations of the PM from calcimy-
cin-treated neu1–/– macrophages contained high quantities of
a LAMP-1 species of higher MW than did similar preparations
from treated WT cells (Figure 5C). The pool of PM-localized
LAMP-1 in KO cells remained unchanged for up to 1 hr upon
withdrawal of Ca2+ from the medium; in contrast, in WT cells
the majority of LAMP-1 was recovered intracellularly at all time
points (Figure 5C). These results suggest that in KO cells a larger
number of lysosomes than in WT cells were docked at the PM
and underwent lysosomal exocytosis exposing LAMP-1 at the
cell surface.
Finally, purification of PM fractions with a sialic acid-specific
lectin demonstrated that LAMP-1 from both KO and WT cells
was sialylated at the PM, albeit the MW of KO-LAMP-1 was
higher than that of WT-LAMP-1 because of differential sialic
acid content (Figure 5D). We also measured increased extracel-
lular activity of b-hexosaminidase (b-hex) and a-mannosidase
(a-man) in the medium of neu1–/– cells, which confirmed their
enhanced lysosomal exocytosis (Figure 5E).
NEU1 Activity in Sialidosis Fibroblasts Inversely
Correlates with LAMP-1 Levels at the PM
and Lysosomal Exocytosis
We next tested whether the phenotypic abnormalities seen in
NEU1-deficient murine macrophages were reproduced in fibro-
blasts from sialidosis patients (Bonten et al., 2000). Two of these
patients presented at birth with the congenital early onset form of
the disease (Type II) and carried neu1 mutations that completely
eliminated NEU1 activity; the third was a late onset patient with
residual lysosomal NEU1 activity and an attenuated form of siali-
dosis (Type I). All of the tested sialidosis fibroblasts had increased
levels of LAMP-1 in the total cell lysate compared to the normal
fibroblasts (Figure 5F). LAMP-1 was nearly absent in purified
PM fractions isolated from normal fibroblasts, reflecting the pref-
erential LM localization of the protein in these cells (Figure 5F).
In contrast, PM fractions from sialidosis fibroblasts showed a
clear correlation between disease severity and the levels of cell
surface LAMP-1 (Figure 5F). The increased levels of LAMP-1 at
the PM of the type II sialidosis fibroblasts were accompanied
by higher extracellular activity of a-man, indicative of increased
exocytosis (Figure 5G). The relatively low levels of LM-localized
LAMP-1 in the type II sialidosis fibroblasts reflected a clear
redistribution of this protein from the LM to the PM (Figure 5F).
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NEU1-Regulated Exocytosis of LysosomesFigure 5. Enhanced Lysosomal Exocytosis
in Neu1–/– Macrophages and Type II Sialido-
sis Fibroblasts and Increased Levels of
LAMP-1 at the Cell Surface
(A) Comparison of immunofluoresence staining of
permeabilized and nonpermeabilized WT or KO
macrophages with LAMP-1 antibodies (L1418 or
1D4B), followed by LSCM; PM distribution of
LAMP-1 (arrows) in nonpermeabilized KO macro-
phages. Magnification, 1003.
(B) WT and KO macrophages were cultured in the
presence or absence of rBV-Neu1, as indicated.
Cell surface expression of LAMP-1 was detected
by FACS, using anti–LAMP-1 (1D4B). Prior to the
FACS analysis, cultures were incubated in either
normal medium (-EGTA) or in Ca2+-depleted
medium (+EGTA). Dotted graphs represent IgG
isotype controls set at 0%.
(C) Immunoblots of PM and intracellular fractions
isolated from WT and KO macrophages after treat-
ment with calcimycin, followed by culture of the
cells in Ca2+-free medium for different time points
(0, 15, 30, and 60 min).
(D) PM preparations from WT and KO macro-
phages were purified with a sialic acid-specific
lectin and analyzed on immunoblots with anti-
LAMP-1 (L1418). Cell lysates were included as
controls.
(E) Increased b-hex and a-man activities in the me-
dium of KO cells compared to WT. Enzyme activ-
ities represent the mean ± SEM.
(F) PM and lysosomal preparations purified from
normal fibroblasts, type I (mild), and type II (severe)
sialidosis fibroblasts were analyzed on immuno-
blots with anti-LAMP-1 (L1418). Total cell lysates
were used as controls. For equal loading, mem-
branes were incubated with anti-actin (cell
lysates), anti-CA (lysosomes), and anti-fibroblast
surface protein (FSP; PM).
(G) Increased a-man activity was measured in the
medium of type II sialidosis fibroblasts. Enzyme
activities represent the mean ± SEM.In contrast, the type I sialidosis fibroblasts showed a near normal
distribution of LAMP-1 (Figure 5F), and in turn no significant in-
crease in lysosomal exocytosis (Figure 5G). Based on these re-
sults, we postulate that also in nonsecretory cells a complete
lack of NEU1 activity results in the redistribution of LAMP-1 to
the PM and the aberrant induction of lysosomal exocytosis.
Neu1–/– Macrophages Form Clusters of Lysosomes
in the Proximity of the PM
It has been shown that lysosomes that are destined to undergo
lysosomal exocytosis are predocked at the PM, a process that
is independent of Ca2+ influx (Jaiswal et al., 2002). We reasoned
that accumulation of LAMP-1 at the cell surface of NEU1-defi-
cient macrophages may not only reflect an increase in lysosomal
exocytosis, but also be indicative of a higher number of pre-
docked lysosomes near the PM. To test this hypothesis we
used total internal reflection microscopy (TIRFM), which allows
the visualization of fluorescently labeled organelles in the evanes-
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2002). The lysosomes of KO and WT macrophages were labeled
with Lysotracker to monitor the number of PM-proximal lyso-
somes present in the TIRF field. b-gal–/– macrophages were
included in this experiment as a control. Lysotracker+ objects
were counted in multiple KO and WT TIRF images, and com-
pared to those present in the epifluorescent field (Figure 6A).
All macrophages had numerous small lysosomes in the TIRF
field, but only the neu1–/– macrophages contained large Lyso-
tracker+ objects (>1 mm) intensely fluorescent (Figure 6A and
6B). The mean size of these objects in the neu1–/– cells was
approximately 3-fold larger than that in WT and b-gal–/– macro-
phages (Figure 6C). Their irregular shape was suggestive of clus-
ters or aggregates of lysosomes rather than individual enlarged
lysosomes (Figure 6A); moreover, both their shape and fluores-
cence intensity fluctuated in the TIRF field. This fluctuation in sig-
nal was probably caused by the continuous addition and release
of lysosomes to and from these clusters, many of which likely
Developmental Cell
NEU1-Regulated Exocytosis of Lysosomesfusing with the PM. We propose that these clusters in neu1–/–
cells represent dynamic ‘‘lysosome docking stations’’ from
which lysosomal exocytosis occurs.
In agreement with the TIRFM data, electron microscopy (EM)
of cultured neu1–/– cells showed the majority of lysosomes dec-
orating the PM (Figure 6D, middle and left panels). The right
panel gives an example of a lysosome in a KO cell that has
breached the PM and is undergoing exocytosis (arrows).
Figure 6. Neu1–/– Macrophages Have ‘‘Clusters’’ of PM-Proximal
Lysosomes
WT, b-gal–/– (b-gal-KO), and neu1–/– (Neu1-KO) macrophages were incubated
for 30 min with Lysotracker. The cells were analyzed by TIRFM to determine
the number of lysosomes in the evanescent field proximal to the PM.
(A) Representative images of evanescent (TIRF; red in overlay) and epifluores-
cent (Epi; green in overlay) Lysotracker+ cells; multiple large (>1mm) ‘‘clusters’’
(arrows) in the evanescent field of neu1-KO cells. Magnification, 603.
(B) Lysotracker+ objects larger than 1 mm were counted in multiple images of
each cell type (n = 20). The values represent mean objects per cell ± SD.
(C) The mean size of Lysotracker+ objects was calculated for each of the 3 cell
types (n = 20). The values represent mean object size ± SD.
(D) EM of WT and KO macrophages; lysosome that has breached the PM and
is being exocytosed (arrows).LAMP-1 Regulates the Extent of Lysosomal Exocytosis
Given the direct correlation between increased LAMP-1 at the
PM and enhanced lysosomal exocytosis, we asked whether
overexpression of LAMP-1 in WT macrophages would induce
a similar phenotype, albeit without the additional effect of over-
sialylation occurring in Neu1-deficient cells. Western blot analy-
sis of WT cells overexpressing LAMP-1 showed increased levels
of the protein that was paralleled by an increment of a-man
activity in the medium (Figures 7A and 7B). Nonetheless this ac-
tivity was considerably lower than that measured in the medium
of KO cells; therefore, overexpression of wild-type LAMP-1 did
not fully recapitulate the effects of hypersialylated LAMP-1 on
lysosomal exocytosis.
To further support this point, we assessed whether siRNA
silencing of Lamp1 in neu1–/– and neu1+/+ macrophages would
hamper lysosomal exocytosis. This experiment was performed
with or without addition in the medium of calcimycin. As seen
earlier, KO macrophages were especially responsive to calcimy-
cin treatment, which substantially increased the level of exocy-
tosed b-hex; however, this drug had only a marginal effect on
WT macrophages (Figure 7D). Again, these results imply that
NEU1-deficient macrophages contain a larger population of ly-
sosomes docked at the PM and poised for exocytosis. Transfec-
tion of both KO and WT cells with lamp-1 siRNA effectively
reduced LAMP-1 protein levels (Figure 7C). Silencing of lamp-1
mRNA was accompanied by a dramatic inhibition of lysosomal
exocytosis, particularly in deficient cells, reducing extracellular
b-hex activity to levels similar to those measured in the medium
of WT cells (Figure 7D). The b-hex activity did not increase
when calcimycin was added to siRNA-transfected WT and
NEU1-deficient macrophages (Figure 7D).
Finally, we monitored by LSCM the distribution of Lysotracker-
labeled lysosomes in live cells after silencing of LAMP-1.
Contrary to mock-transfected WT macrophages, which had a
relatively random distribution of lysosomes (Figure 7E and Movie
S5), mock-transfected KO macrophages showed clusters of
lysosomes (Figure 7E; arrow). Z stacks imaging of these clusters
confirmed that they were located at or near the cell surface
(Movie S6). Silencing of LAMP-1 completely reversed the forma-
tion of lysosome clusters in neu1–/– macrophages (Figure 7E and
Movies S7 and S8).
Combined, these results suggest that LAMP-1 promotes the
formation of clusters of lysosomes near the cell surface of
neu1–/– macrophages, which are likely responsible for the
increase in exocytosis.
DISCUSSION
In this study we identify an unexpected function of NEU1 as
a negative regulator of LAMP-1, a structural component of the ly-
sosomal membrane. Together with other LM proteins, including
the structurally similar LAMP-2, LAMP-1 was thought to merely
maintain membrane integrity against the harsh lysosomal envi-
ronment, owing to its abundant sugar content (Kundra and Korn-
feld, 1999). KO mice for the individual Lamps have suggested
partial redundancy between the two proteins (Andrejewski
et al., 1999; Tanaka et al., 2000). LAMP-2 has since been recog-
nized as a multitask protein involved in macroautophagy, chap-
erone-mediated autophagy, and lysosomal biogenesis, and
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disease (Cuervo et al., 2003; Eskelinen et al., 2003; Oakes
et al., 2005). On the other hand, LAMP-1 has been implicated
in lysosomal exocytosis (Kima et al., 2000; Reddy et al., 2001).
More recently, both LAMP-1 and Lamp-2 were shown to be
involved in the movement of lysosomes along microtubules,
because double-deficient cells have impaired organelle motility
and a defect in the fusion of phagosomes with lysosomes (Huynh
et al., 2007). Therefore, it is clear that these proteins exert
specialized and regulated functions in different cells.
Our current findings support this notion and put forward
a mechanism of regulation of the intracellular trafficking of
LAMP-1 that hinges on its sialic acid cleavage by NEU1. By con-
trolling the sialic acid content of the luminal domain of LAMP-1,
NEU1 determines its turnover rate and subcellular distribution,
and, in turn, impacts on the physiological process of lysosomal
exocytosis. In neu1–/– BM-derived macrophages, the loss of
Neu1 results in hypersialylated LAMP-1, which has a longer
half-life and is preferentially accumulated at the PM. We provide
evidence that these features of LAMP-1 promote excessive
lysosomal exocytosis of serine proteases in the bone niche of
affected mice and consequent loss of BM retention.
Figure 7. LAMP-1 Regulates the Level of
Lysosomal Exocytosis and Promotes the
Formation of Lysosome Clusters in Neu1–/–
Cells
(A) CMV-LAMP-1-IRES-GFP plasmid DNA was
transfected into WT macrophages, and LAMP-1
expression was analyzed on immunoblot with
anti-LAMP-1; LAMP-1/GFP overexpressing cells
(WT, +); CMV-GFP transfected cells (WT, );
mock-transfected KO cells (KO, ).
(B) WT and KO macrophages were transiently trans-
fected with either CMV-GFP or CMV-LAMP-1-GFP
andFACS-sorted. Thea-manactivitywasmeasured
in the medium of GFP+/rLAMP-1+ WT (WT+rLamp1)
and GFP-/rLAMP-1 WT cells (WT). Enzyme activi-
ties are expressed as the mean ± SEM.
(C) WT and KO macrophages were transfected
with lamp-1 siRNA or mock-transfected, in pres-
ence or absence of calcimycin. Cell lysates were
analyzed on an immunoblot probed with anti-
Lamp1 antibody.
(D) b-hex activity measured in the medium of
mock or lamp-1-siRNA-transfected WT and KO
macrophages, in the presence or absence of
calcimycin. Enzyme activities are expressed as
mean ± SEM.
(E) WT and KO macrophages were either mock- or
lamp-1-siRNA transfected. After transfection the
cells were incubated with Lysotracker and ana-
lyzed by LSCM. Magnification, 603.
Two events must occur with precision
for lysosomes to undergo exocytosis,
both of which may be differentially regu-
lated in different cell types: the recruit-
ment/docking of lysosomes to the PM,
which is a Ca2+-independent process,
and the actual fusion of the LM with the
PM, which is strictly dependent on Ca2+
influx (Jaiswal et al., 2002). We found no evidence that the ab-
sence of NEU1 has any effects on the fusion of lysosomes with
the PM, because the MW or stability of T- and V- SNAREs, and
Syt VII, which are involved in the LM-PM fusion during lysosomal
exocytosis (Shen et al., 2005; Tucker et al., 2004; Rizo et al.,
2006), remain unaltered in KO cells. However, inhibition of
LAMP-1 expression effectively blocks exocytosis in neu1–/– mac-
rophages and alters lysosome distribution, directly implicating
LAMP-1 in the recruitment and/or docking of lysosomes to the
PM. Several proteins, including Rab GTPases and motor myo-
sins, are needed for the attachment of lysosomes to microtubules
and subsequentdelivery to the actincytoskeleton at the periphery
of the cell (Bossi et al., 2005). We can speculate that the highly
conserved cytosolic tail of LAMP-1 interacts with components
of this transport machinery. However, as is the case for many re-
ceptor-ligand interactions, by controlling the sialic acid content of
the LAMP-1 luminal domain, NEU1 may actually alter the charge/
conformation of the cytosolic tail of the protein at the other side of
the LM and, thereby, change its binding affinity toward its inter-
acting partners. On the other hand, the extent by which LAMP-
1 is involved in lysosomal exocytosis could simply be dictated
by its overall quantity. In the absence of NEU1 a larger pool of
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exocytosis. Our findings support both concepts because (1)
those cells with no residual NEU1 activity have the highest levels
of LAMP-1 at the PM (Type II sialidosis); and (2) increasing
Lamp-1 expression in WT cells failed to fully recapitulate the
same extent of lysosomal exocytosis observed in neu1–/– cells.
Therefore, while in neu1–/– deficient mice enhanced lysosomal
exocytosis clearly plays a strong pathophysiological role, it re-
mains to be determined whether NEU1-regulated processing of
LAMP-1 significantly contributes to the physiological modes of
exocytosis during normal development and homeostasis. It
would be relevant to test this idea in lamp-1/neu1 double KO
mice. Unfortunately, neu1/ mice breed poorly (de Geest
et al., 2002) and lamp-1/ mice are currently not available.
Therefore, this represents a long-term project for the future.
We focused on understanding the consequences of in-
creased lysosomal exocytosis in the bone niche in an attempt
to characterize the molecular mechanism of EMH in sialidosis
mice (de Geest et al., 2002). We found a dramatic inactivation
of serpina1 and serpina3 in the neu1–/– BMEF, coupled with
mobilization of HPCs into the peripheral blood. Consequently,
we detected a loss of intracellular staining of the neutrophil
serine proteases NE and CG and corresponding increases of
these proteins extracellularly, resulting in the degradation of
VCAM-1 needed for the retention of HPCs. These findings
agree with earlier studies that showed downregulation of ser-
pina1 and serpina3 upon massive release of neutrophil serine
proteases following BM mobilization induced by G-CSF or che-
motherapy (Winkler et al., 2005). Thus, a shift in the balance be-
tween serine proteases and serpins in the ECM of the neu1–/–
bone niche may contribute to the increased number of HPCs
in the spleen of neu1–/– mice, consistent with splenic EMH,
and to the impaired long-term BM engraftment in sialidosis
mice. Notably, patients with sialidosis exhibit a profound en-
largement of the liver and spleen (Thomas, 2001), which could
also be caused by NEU1-induced EMH.
In conclusion, this study introduces a mechanism for regula-
tion of lysosomal exocytosis, which depends on the level of sia-
lylation of LAMP-1 controlled by NEU1 and underscores the
importance of this enzyme in lysosomal biogenesis and hemato-
poiesis in the bone niche (Figure 8). Moreover, to our knowledge,
sialidosis is the only genetic disease known to date that is asso-
ciated with increased lysosomal exocytosis, and it is likely that
deregulation of this process underlies other phenotypic abnor-
malities in this complex multisystemic disease.
Figure 8. Schematic Representation of the Events that Lead to Loss
of BM and Splenic EMH in NEU1-Deficient MiceEXPERIMENTAL PROCEDURES
Animals
All procedures in mice were performed according to animal protocols
approved by our Institutional Animal Care and Use Committee and NIH guide-
lines. neu1–/– and neu1+/+ mice were bred into the FVB/NJ genetic
background.
Cell Culture
Human skin fibroblasts from controls and sialidosis patients were cultured as
described (Bonten et al., 2000). Primary macrophage and BMSC cultures were
established from freshly isolated BM of WT or NEU1-deficient mice according
to the procedure of Sklar et al., (1985).
Antibodies, Recombinant Proteins, and Protease Inhibitors
We used the following commercial antibodies: polyclonal anti-LAMP-1 raised
against the C-terminal cytosolic peptide (Sigma; L1418); monoclonal anti-
LAMP-1 against the luminal domain (clone 1D4B, Santa Cruz Biotechnology);
polyclonal anti-Lamp-2 (Ipg96, Invitrogen); polyclonal anti-NE and -CG (Santa
Cruz Biotechnology); polyclonal anti-SNAP23 (Santa Cruz Biotecnology); poly-
clonal anti-Syntaxin4 (Sigma); monoclonal anti-VAMP7 (Abcam); polyclonal
Synaptotagmin VII (Synaptic Systems); polyclonal anti-actin (Cell Signaling);
monoclonal anti-fibroblast surface protein (Novus Biologicals). Recombinant
proteins, anti-SERPINA1, anti-SERPINA3, and anti-VCAM-1/CD106 were
from R&D Systems. FITC-, CY3-, and HRP-conjugated secondary antibodies
were from Jackson Immuno Research. Polyclonal anti Neu1- and anti-CA
antibodies have been previously described (Bonten et al., 2004). Elastase
inhibitor III and CG inhibitor were from EMD Bioscience, and PMSF was
from Sigma.
IHC and Microscopy
IHC of tissue sections and immunofluorescence (IF) of permeabilized macro-
phages were performed as described (Bonten et al., 2004; de Geest et al.,
2002). For IF of nonpermeabilized cells the fixation was done in ice-cold
ultrapure paraformaldehyde (4%-w/v) and gluteraldehyde (5%-w/v). For
Lysotracker-fluorescence microscopy, macrophages were seeded in glass-
bottom Fluorodishes (World Precision Instruments), and incubated for 30
min at 37C in medium containing 200 nM Lysotracker (DND-99, Invitrogen).
TIRFM of live Lysotracker-labeled macrophages was performed with a Maria-
nas imaging system (Intelligent Imaging Innovations/3i) consisting of a Carl
Zeiss 200M motorized inverted microscope and TIRF illuminator (Carl Zeiss
MicroImaging) and a DPSS 561 nm laser (Cobolt). Images were acquired
with a Zeiss Alpha Plan-Fluar 100 3 1.45 NA objective on a CoolSNAP HQ 2
CCD camera (Photometrics), using SlideBook 4.2 software (3i). LSCM on
Lysotracker-stained live cells was performed with a Nikon TE2000-E inverted
microscope equipped with a C1Si confocal system, an argon ion laser at 488
nm and a 561 nm DPSS laser (Melles Griot). Images were taken using a Nikon
Plan Apochromat 60 3 1.4 NA objective. LSCM on fixed tissues was per-
formed with a Zeiss Axioplan 2 upright microscope equipped with an LSM
510 NLO confocal system (Carl Zeiss MicroImaging), a Mira 900 Ti Sapphire
laser (Coherent Inc.), an argon ion laser at 488 nm, and a HeNe laser at 543
nm. Images were acquired with a Zeiss Plan-Neofluar 40 3 1.3 NA objective.
Three-dimensional renderings were created from z stack acquisitions using
Imaris 6.0 software (Bitplane). For EM studies, macrophages were fixed and
embedded using standard protocols and sections (600–900 A˚) were stained
in grids and visualized using a JEOL:-JEM 1200EX II Electron Microscope
and a Gatan 782 Digital Camera.
Biochemical Analyses and Enzyme Assays
Enzyme activities were measured with the appropriate fluorimetric or colori-
metric substrates (Galjart et al., 1991; Levesque et al., 2001). Cathepsin
B and L were assayed using InnoZyme activity assay kits (EMD Biosciences).
To measure enzyme activities in the medium, cells were incubated in medium
containing 1% BSA (w/v). Protein concentrations were determined using the
BCA-assay (Pierce Biotechnology). Uptake of rBV-NEU1 by macrophages
was performed as described (Bonten et al., 2004).
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on an SDS-polyacrylamide gel using the ECL-glycoprotein detection system
(Pierce Biotechnology) following the manufacturer’s protocol.
BMEF was isolated from femurs and tibias of each mouse as described
(Levesque et al., 2001).
Macrophage lysates (5 mg) were resolved on reduced 4%–12% Bis-Tris
SDS-acrylamide gels (Invitrogen) and blotted against PVDF membranes
(Millipore), which were subsequently probed with above listed antibodies.
Macrophage lysates were N- and O-deglycosylated using the Enzymatic De-
glycosylation Kit (Prozyme), following the manufacturer’s protocol, and ana-
lyzed on western blots.
Recombinant VCAM-1 (50 ng) or BMSC suspensions were proteolytically
digested with 30 ml BMEF (Levesque et al., 2001) and incubated at 37C for
up to 16 hr. Proteolytic fragments were analyzed on western blots using
anti-VCAM-1 antibody.
Metabolic pulse-chase labeling of macrophages with 35S-methionine, im-
munoprecipitation of radiolabeled proteins with anti-LAMP-1 or anti-Lamp-2
antibodies, and autoradiography were performed as described (Proia et al.,
1984; Zhou et al., 1996). Band intensity was determined using the Chemidoc
system (Bio Rad).
Casein zymograms (Bio Rad) were performed on BMEFs from 2-month-old
neu1–/– mice and developed in the presence or absence of selective inhibitors
for CG and elastase according to the manufacturer’s instructions (EMD Biosci-
ences).
PM proteins were isolated from cultured macrophages and human sialidosis
fibroblasts using the Cell Surface Protein Isolation kit (Pierce) and the Qpro-
teome Plasma Membrane Protein Kit (QIAGEN), respectively. Lysosomes
were purified from fibroblasts as described (Storrie and Madden, 1990). Sialic
acid-containing PM proteins were isolated using the Qproteome Glycoprotein
Fractionation Kit (QIAGEN) and further purified on sialic acid-binding lectin
spin columns (MAL). Purified proteins (30 mg) were analyzed on immunoblots.
To induce LM-PM fusion of docked lysosomes and extracellular release of
their luminal content, cultured cells were incubated for 2 min in medium con-
taining 10 mM Calcimycin A23187 (Sigma) in the presence of 1.2 mM CaCl2, af-
ter which the cells were washed with Ca2+-free PBS and further maintained in
Ca2+-free medium containing 10 mM EGTA.
Northern Blot Analysis
Total RNA was isolated from 2x107 cultured wild-type and neu1–/– macro-
phages using Trizol (Invitrogen) according to manufacturer’s protocol. A north-
ern blot was prepared with 10 mg RNA per sample and probed with full-length
32P-dATP-labeled lamp-1 cDNA insert, using standard DNA/RNA techniques.
Cell Adhesion Assays, and Analyses of HPCs
in the BM and Peripheral Blood
For cell adhesion assays BMSCs were incubated for 1 hr at 37C with increas-
ing concentrations of KO or WT BMEF, after which calcein-AM-labeled HPCs
were added and allowed to adhere for 1 hr. After washing, the retained HPCs
were quantified on a TRIAD plate reader (Ex485, Em530; Dynex). Fluorescence
readings were standardized against calcein-AM labeled HPCs. Bone marrow
and peripheral blood were isolated from 3-month-old KO and WT mice (n = 4)
and stained with lineage-specific antibodies, and c-Kit+/Sca1+/Lin– HPCs
were FACS-sorted. For FACS analyses, cells were incubated for 30 min with
fluorochrome-conjugated primary antibodies (0.5–1 mg/1 3 106 cells/50 ml).
Isotype controls matched the isotypes of the experimental antibodies. Cells
were then analyzed on a flow cytometer (FCS LASR II; BD Biosciences).
Two-Dimensional Electrophoresis
BMEF samples from 2-month-old neu1+/+ and neu1–/– littermates were
TCA-precipitated and resolved in the first dimension on isoelectric focusing
gels using broad pH-range ampholytes (pH = 4–10). Reduced proteins were
separated in the second dimension on 10% SDS-polyacrylamide gels and
stained with SYPRO Ruby (InVitrogen). Gel spots were excised and analyzed
by MALDI TOFF mass spectrometry. Proteomic experiments were performed
at the Hartwell Center core facility of SJCRH.
84 Developmental Cell 15, 74–86, July 2008 ª2008 Elsevier Inc.LAMP-1 Overexpression in Macrophages
Full-length mouse lamp-1 cDNA (IMAGE: 5716524) was subcloned into the
mammalian expression vector pIRES2smGFP (http://plasmid.hms.harvard.
edu). Macrophages were transiently transfected with either CMV-LAMP-1-
IRES-GFP or with CMV-GFP using the Mouse Macrophage Nucleofector
electroporation kit and the Nucleofector II electroporation device (Amaxa Bio-
systems). The average transfection efficiency was 50%–60%. GFP-express-
ing cells were sorted by FACS 24 hr after electroporation, and GFP-positive
and -negative cells were cultured for an additional 3 days prior to enzyme
activity assays.
Silencing of LAMP-1 Expression in Macrophages
by siRNA Transfection
WT and Neu1-deficient macrophages were seeded in 6-well dishes at 50%
confluency a day before transfection. Cells were transfected with On-Target-
plus Smartpool lamp-1 siRNA (Dharmacon) using Dharmafect-4 transfection
reagent. All transfections were performed in triplicate. Two days after transfec-
tion, the medium was replaced with 1 ml serum-free medium plus or minus
10 mM Calcimycin A23187 (Sigma-Aldrich). After 30 min incubation, the
medium was collected and assayed for b-hex activity. Cells were analyzed
on western blots or by LSCM.
SUPPLEMENTAL DATA
Supplemental Data include four figures and eight movies and are available with
this article online at http://www.developmentalcell.com/cgi/content/full/15/1/
74/DC1/.
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